January 2022 Issue

GO TO FULL ISSUE

Editor's Picks

Coronavirus

NEW YEAR'S RESOLUTIONS

Med Updates

Lybalvi
olanzapine/samidorphan
Combination atypical antipsychotic and opioid antagonist for schizophrenia and bipolar I disorder

Vuity
pilocarpine 1.25% solution
A new eye drop for "presbyopia," or age-related difficulty seeing up close

Kerendia
finerenone
A non-steroidal mineralocorticoid receptor antagonist for patients with chronic kidney disease associated with type 2 diabetes

OTHER MED UPDATES

New! RxAdvanced: Leadership & Communication. Advanced training for pharmacists that covers the gamut of everyday pharmacy interactions. Learn More.

New CE and Training


Popular Charts